Market Research Logo

Evotec AG - Product Pipeline Review - 2016

Evotec AG - Product Pipeline Review - 2016

Summary


Global Markets Direct’s, ‘Evotec AG - Product Pipeline Review - 2016’, provides an overview of the Evotec AG’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Evotec AG, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

  • The report provides a snapshot of the pipeline therapeutic landscape of Evotec AG
  • The report provides overview of Evotec AG including its business description, key facts, and locations and subsidiaries
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report assesses Evotec AG’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report features Evotec AG’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects
Reasons to buy
  • Evaluate Evotec AG’s strategic position with total access to detailed information on its product pipeline
  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of therapeutics under development for Evotec AG
  • Identify potential new clients or partners in the target demographic
  • Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
  • Devise corrective measures for pipeline projects by understanding Evotec AG’s pipeline depth and focus of pipeline therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope


Evotec AG Snapshot
Evotec AG Overview
Key Information
Key Facts
Evotec AG - Research and Development Overview
Key Therapeutic Areas
Evotec AG - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Pipeline Products - Partnered Products
Partnered Products/Combination Treatment Modalities
Pipeline Products - Out-Licensed Products
Out-Licensed Products/Combination Treatment Modalities
Evotec AG - Pipeline Products Glance
Evotec AG - Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Evotec AG - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
Evotec AG - Drug Profiles
EVT-201
Product Description
Mechanism of Action
R&D Progress
EVT-401
Product Description
Mechanism of Action
R&D Progress
Drug to Inhibit KDM for Oncology
Product Description
Mechanism of Action
R&D Progress
Drugs for Endometriosis
Product Description
Mechanism of Action
R&D Progress
EVT-070
Product Description
Mechanism of Action
R&D Progress
EVT-601
Product Description
Mechanism of Action
R&D Progress
EVT-701
Product Description
Mechanism of Action
R&D Progress
EVT-801
Product Description
Mechanism of Action
R&D Progress
Small Molecules for Pain
Product Description
Mechanism of Action
R&D Progress
Small Molecules to Inhibit PDE10A for Schizophrenia and Psychosis
Product Description
Mechanism of Action
R&D Progress
Cell Therapy for Type 1 Diabetes and Type 2 Diabetes
Product Description
Mechanism of Action
R&D Progress
Drug for Kidney Diseases
Product Description
Mechanism of Action
R&D Progress
Drugs for Alzheimer's Disease
Product Description
Mechanism of Action
R&D Progress
Drugs for Multiple Sclerosis
Product Description
Mechanism of Action
R&D Progress
Drugs for Tissue Fibrosis
Product Description
Mechanism of Action
R&D Progress
Drugs to Inhibit FGFR3 for Bladder Cancer
Product Description
Mechanism of Action
R&D Progress
Drugs to Target EEM for Type 1 Diabetes and Type 2 Diabetes
Product Description
Mechanism of Action
R&D Progress
Induced Pluripotent Stem Cells for Amyotrophic Lateral Sclerosis
Product Description
Mechanism of Action
R&D Progress
Small Molecules for Chronic Kidney Disease
Product Description
Mechanism of Action
R&D Progress
Small Molecules for Dysferlinopathies
Product Description
Mechanism of Action
R&D Progress
Small Molecules for Glioblastoma Multiforme
Product Description
Mechanism of Action
R&D Progress
Small Molecules for Huntington Disease
Product Description
Mechanism of Action
R&D Progress
Small Molecules for Inflammation
Product Description
Mechanism of Action
R&D Progress
Small Molecules for Multiple Sclerosis
Product Description
Mechanism of Action
R&D Progress
Small Molecules for Neurodegenerative diseases
Product Description
Mechanism of Action
R&D Progress
Small Molecules for Solid Tumor
Product Description
Mechanism of Action
R&D Progress
Small Molecules to Agonize Orexin Receptor 2 for Nacrcolepsy
Product Description
Mechanism of Action
R&D Progress
Small Molecules to Inhibit PGB for Bacterial Infections
Product Description
Mechanism of Action
R&D Progress
Evotec AG - Pipeline Analysis
Evotec AG - Pipeline Products by Target
Evotec AG - Pipeline Products by Route of Administration
Evotec AG - Pipeline Products by Molecule Type
Evotec AG - Pipeline Products by Mechanism of Action
Evotec AG - Recent Pipeline Updates
Evotec AG - Dormant Projects
Evotec AG - Discontinued Pipeline Products
Discontinued Pipeline Product Profiles
EVT-301
sembragiline
ocaperidone
REN-1654
REN-213
REN-850
Evotec AG - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Evotec AG, Key Information
Evotec AG, Key Facts
Evotec AG - Pipeline by Indication, 2016
Evotec AG - Pipeline by Stage of Development, 2016
Evotec AG - Monotherapy Products in Pipeline, 2016
Evotec AG - Partnered Products in Pipeline, 2016
Evotec AG - Partnered Products/ Combination Treatment Modalities, 2016
Evotec AG - Out-Licensed Products in Pipeline, 2016
Evotec AG - Out-Licensed Products/ Combination Treatment Modalities, 2016
Evotec AG - Phase II, 2016
Evotec AG - Phase I, 2016
Evotec AG - Preclinical, 2016
Evotec AG - Discovery, 2016
Evotec AG - Pipeline by Target, 2016
Evotec AG - Pipeline by Route of Administration, 2016
Evotec AG - Pipeline by Molecule Type, 2016
Evotec AG - Pipeline Products by Mechanism of Action, 2016
Evotec AG - Recent Pipeline Updates, 2016
Evotec AG - Dormant Developmental Projects,2016
Evotec AG - Discontinued Pipeline Products, 2016
Evotec AG, Subsidiaries
List of Figures
Evotec AG - Pipeline by Top 10 Indication, 2016
Evotec AG - Pipeline by Stage of Development, 2016
Evotec AG - Monotherapy Products in Pipeline, 2016
Evotec AG - Partnered Products in Pipeline, 2016
Evotec AG - Out-Licensed Products in Pipeline, 2016
Evotec AG - Pipeline by Target, 2016
Evotec AG - Pipeline by Molecule Type, 2016
Evotec AG - Pipeline Products by Mechanism of Action, 2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report